The stable raw materials prices, focused cost improvement initiatives and intensified customer acquisitions helped the company to improve its margin profile
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
Investment will fund expansion to meet rising demand for CRDMO services
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Pharma CDMO business has posted a 40% YoY in Q2 driven by BD efforts and backed by macro tailwinds
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Subscribe To Our Newsletter & Stay Updated
